The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo

Published:2013-02-12 Issue:7 Volume:19 Page:1717-1728
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zhou Ning,Singh Kamini,Mir Maria C.,Parker Yvonne,Lindner Daniel,Dreicer Robert,Ecsedy Jeffrey A.,Zhang Zhongfa,Teh Bin T.,Almasan Alexandru,Hansel Donna E.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge mapping of AURKA in Oncology：An advanced Bibliometric analysis (1998–2023);Heliyon;2024-06

2. Alisertib exerts KRAS allele‑specific anticancer effects on colorectal cancer cell lines;Experimental and Therapeutic Medicine;2023-04-11

3. Integrative Bioinformatics Analysis of Transcriptomic Data Reveals Hub Genes as Diagnostic Biomarkers for Non-Muscle vs. Muscle Invasive Bladder Cancer;2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI);2022-09-27

4. Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence;Medical Oncology;2022-09-07

5. A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer;Cancer Chemotherapy and Pharmacology;2022-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP